BioMedha is a UK-based pre-clinical CRO providing in vitro biology drug discovery expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process, such as:
✓ Immunology studies (whole blood, PBMC, monocytes, T-cell,
Neutrophils, B cells, dendritic cells, and macrophages)
✓ Expression studies (protein levels and mRNA levels)
✓ Functional Studies (Receptor, pathway signalling, bioassays)
✓ Cytokine assays and Immunogenicity assessment (Multiplexing)
✓ Mitochondrial function and toxicity assessment
✓ Drug combination studies
✓ Cell health assays (Oncology)
✓ GPCRs: Assay development and screening
✓ Biochemical assays
We serve clients in pharma and biotech as well as virtual companies and academic institutions. BioMedha specializes in bioscience in-vitro biology capabilities and offers bespoke, high-quality services tailored for client needs.
Location: United Kingdom, England, Nottingham
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | BioCity | biocity.co... |